BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma J, Jiang Y, Gong G. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. Eur J Gastroenterol Hepatol 2013;25:428-34. [PMID: 23358121 DOI: 10.1097/MEG.0b013e32835cb5dd] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Parikh P, Ryan JD, Tsochatzis EA. Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection. Ann Transl Med. 2017;5:40. [PMID: 28251119 DOI: 10.21037/atm.2017.01.28] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 7.4] [Reference Citation Analysis]
2 Demir M, Grünewald F, Lang S, Schramm C, Bowe A, Mück V, Kütting F, Goeser T, Steffen HM. Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients. Medicine (Baltimore) 2016;95:e4602. [PMID: 27661015 DOI: 10.1097/MD.0000000000004602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
3 Chen Y, Li Y, Li N, Fan X, Li C, Zhang P, Han Q, Liu Z. A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels. Dis Markers 2018;2018:3924732. [PMID: 30405859 DOI: 10.1155/2018/3924732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Das A, Kamrul-Hasan A, Kabir MR, Das S, Zaki K, Al Mahtab M. Evaluation of Chitinase 3-like 1 (CHI3L1) as a noninvasive biomarker of hepatic fibrosis in patients with Hepatitis B virus-related compensated chronic liver disease. J Family Med Prim Care 2021;10:1694-8. [PMID: 34123914 DOI: 10.4103/jfmpc.jfmpc_1922_20] [Reference Citation Analysis]
5 Ji F, Liang Y, Fu SJ, Guo ZY, Shu M, Shen SL, Li SQ, Peng BG, Liang LJ, Hua YP. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI). BMC Cancer 2016;16:137. [PMID: 26907597 DOI: 10.1186/s12885-016-2189-1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 9.7] [Reference Citation Analysis]
6 Yang Q, Wang Y, Guan X, Gu Y, Li LP, Dai WY, Bian L, Shang N. Evaluation of liver fibrosis by non-invasive diagnostic indexes in patients with chronic hepatitis B. Shijie Huaren Xiaohua Zazhi 2020; 28(22): 1137-1144 [DOI: 10.11569/wcjd.v28.i22.1137] [Reference Citation Analysis]
7 Dimzova M, Kondova-Topuzovska I, Bosilkovski M, Ivanovski L, Milenkovic Z, Semenakova-Cvetkovska V, Orovcanec N. Noninvasive Biomarkers in Assessment of Liver Fibrosis in Patients with HBeAg Negative Chronic Hepatitis B. Open Access Maced J Med Sci 2018;6:1052-8. [PMID: 29983800 DOI: 10.3889/oamjms.2018.122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Korkmaz P, Demirturk N, Batırel A, Cem Yardimci A, Cagir U, Atakan Nemli S, Korkmaz F, Zeynep Akcam F, Sener Barut H, Bayrak B, Karakecili F, Tarakci H, Yulugkural Z, Yuksel E, Aktug Demir N, Ural O, Sumer S, Harman R, Kadanali A, Ozturk S, Cetin Akhan S, Eren Tulek N, Keten D, Sener A, Aygen B, Kocagul Celikbas A, Yilmaz Karadag F, Aydin G, Arslan E, Sacligil C, Akengin Ocal G, Tanoglu A, Ulcay A, Karagoz E, Saltoglu N, Sırmatel F, Akdeniz H, Aynıoglu A, Arslan Ozel S, Dirgen Caylak S, Celik I, Alpay Y, Bestepe Dursun Z, Bekcibasi M, Tuncer Ertem G, Tigli A, Sargin Altunok E, Avsar K, Suer K, Sayan M. Noninvasive Models to Predict Liver Fibrosis in Patients with Chronic Hepatitis B: A Study from Turkey. Hepat Mon 2017;In Press. [DOI: 10.5812/hepatmon.60266] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Balta S, Kucuk U, Arslan Z, Unlu M, Demirkol S. Mean platelet volume may be confused in many conditions. Wien Klin Wochenschr 2014;126:248-9. [PMID: 24337593 DOI: 10.1007/s00508-013-0490-4] [Reference Citation Analysis]
10 Liu KJ, Lv YX, Niu YM, Bu Y. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.Medicine (Baltimore). 2020;99:e23339. [PMID: 33235099 DOI: 10.1097/MD.0000000000023339] [Reference Citation Analysis]
11 Cao Y, Hu ZD, Liu XF, Deng AM, Hu CJ. An MLP classifier for prediction of HBV-induced liver cirrhosis using routinely available clinical parameters. Dis Markers 2013;35:653-60. [PMID: 24302810 DOI: 10.1155/2013/127962] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
12 Zhou H, Long J, Hu H, Tian CY, Lin SD. Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria. World J Gastroenterol 2019; 25(35): 5323-5333 [PMID: 31558876 DOI: 10.3748/wjg.v25.i35.5323] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
13 Zhu GQ, Wang K, Wang B, Zhou YJ, Yang Y, Chen EB, Zhou ZJ, Zhou SL, Shi YH, Zhou J, Dai Z. Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization. Cancer Manag Res 2019;11:63-79. [PMID: 30588111 DOI: 10.2147/CMAR.S186150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
14 Shoaei SD, Sali S, Karamipour M, Riahi E. Non-invasive histologic markers of liver disease in patients with chronic hepatitis B. Hepat Mon 2014;14:e14228. [PMID: 24693307 DOI: 10.5812/hepatmon.14228] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
15 Zhang Z, Wang G, Kang K, Wu G, Wang P. The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection. PLoS One 2016;11:e0152757. [PMID: 27050531 DOI: 10.1371/journal.pone.0152757] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
16 Li Y, Chen Y, Zhao Y. The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. PLoS One. 2014;9:e105728. [PMID: 25165830 DOI: 10.1371/journal.pone.0105728] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
17 Wu J, Mao W. Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases. Dis Markers 2020;2020:2471252. [PMID: 32774512 DOI: 10.1155/2020/2471252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Huang J, Yang Y, Xia Y, Liu FC, Liu L, Zhu P, Yuan SX, Gu FM, Fu SY, Zhou WP, Liu H, Jiang BG, Pan ZY. Prediction of Patient Survival Following Hepatic Resection in Early-Stage Hepatocellular Carcinoma with Indexed Ratios of Aspartate Aminotransferase to Platelets: A Retrospective Cohort Study. Cancer Manag Res 2021;13:1733-46. [PMID: 33642875 DOI: 10.2147/CMAR.S284950] [Reference Citation Analysis]
19 Kuetting F, Lang S, Schramm C, Kasper P, Goeser T, Steffen H, Demir M. FIB-4 Is a Potential Tool for Hepatocellular Carcinoma Risk Stratification in Ethnically Diverse Chronic Hepatitis B Patients When Using Specific Cutoff Values. Hepat Mon 2019;In Press. [DOI: 10.5812/hepatmon.94574] [Reference Citation Analysis]
20 Zeng DW, Dong J, Liu YR, Jiang JJ, Zhu YY. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol 2016; 22(29): 6663-6672 [PMID: 27547009 DOI: 10.3748/wjg.v22.i29.6663] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
21 Wu S, Tu R, Liang X. Patchy echogenicity of the liver in patients with chronic hepatitis B does not indicate poorer elasticity. Ultrasonography 2019;38:327-35. [PMID: 31302950 DOI: 10.14366/usg.18071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]